Autres langues Hla Group Corp., Ltd.

Actions

600398

CNE0000016H3

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 20/05/2024			Varia. 5j.	Varia. 1 janv.
9,24 ^CNY	-1,28 %		-4,05 %	+24,53 %

29/04	Hla Group Corp. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
29/04	Hla Group Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hla Group Corp., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Hla Group Corp., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Ose Immuno a reçu un financement de Bpifrance	11/04
HLA to Redeem Convertible Bonds Early	19/03
Diamyd Medical Secures US FDA Fast Track Designation for Type 1 Diabetes Treatment	15/02
OSE Immuno : accord de collaboration avec GenDx	21/11
Diamyd Medical Partners With DiaUnion for Diabetes Drug Trial	07/11
Hla Group Corp., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Diamyd Medical Reports Updated Data on Subcutaneous Treatment to Delay Type 1 Diabetes Onset in Kids	26/10/23
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation	24/10/23
Diamyd Medical’s Diabetes Drug Shows Booster Safety in Mid-stage Study; Shares Jump	20/10/23
IDEAYA Biosciences Initiates Phase 2 Expansion of Combination Therapy for Metastatic Cutaneous Melanoma	16/10/23
Healthia Expands North American Laboratory Operations	12/10/23
Hla Group Corp., Ltd.(XSSC:600398) added to S&P Global BMI Index	18/09/23
Hla Group Corp., Ltd.(XSSC:600398) added to FTSE All-World Index	18/09/23
OSE Immunotherapeutics' Lung Cancer Vaccine Extends Survival in Late-stage Study	12/09/23
China Manufacturing Gloom Tempers Gains of Australian Equities	31/08/23
Healthia Receives AU$260 Million Acquisition Bid from Pacific Equity Partners	31/08/23
Hla Group Corp., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
BriaCell Therapeutics Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer	16/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hla Group Corp., Ltd.

Actions

600398

CNE0000016H3

Autres langues

Filtres